OpenVSafe by OpenVAERS
Search V-safe

YK6-26675-47169

4 vaccinations 1 coded response 34 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
605 / IL
Registered
2021-03-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
ZP5-20364-67503 Child or adolescent in my care · Female · 2022-06-25

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-30
    Registered in v-safe
  3. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-07
    Health check-in — day 7, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  10. 2021-04-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-19
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  15. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-31
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-18
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-12-02
    Dose 3 — Pfizer-BioNTech
  27. 2022-04-19
    Survey response — 12 months, dose 2
    MedDRA: Antiphospholipid syndrome — Feeling: Good
    Free text: Antiphospholipid syndrome
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-09-11
    Dose 4 — Moderna
  29. 2022-09-12
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  30. 2022-09-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  31. 2022-09-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  32. 2022-09-18
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  33. 2022-09-25
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-10-02
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-10-09
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-10-16
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-10-23
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-12-11
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  39. 2023-03-12
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech
22021-04-19Pfizer-BioNTech
32021-12-02Pfizer-BioNTech No
42022-09-11Moderna No

Free text

Release 11 — 12 months, dose 2

2022-04-19

Symptoms: Antiphospholipid syndrome

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAntiphospholipid syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…